| Ident. | Authors (with country if any) | Title |
|---|
| 004B19 |
D. Dressler [Royaume-Uni] ; G. Dirnberger [Royaume-Uni] ; K. P. Bhatia [Royaume-Uni] ; A. Irmer [Allemagne] ; N. P. Quinn [Royaume-Uni] ; H. Bigalke [Allemagne] ; C. D. Marsden [Royaume-Uni] | Botulinum toxin antibody testing: Comparison between the mouse protection assay and the mouse lethality assay |
| 004B89 |
D. Dressier [Royaume-Uni] ; G. Dirnberger [Royaume-Uni] ; K. P. Bhatia [Royaume-Uni] ; A. Irmer [Allemagne] ; N. P. Quinn [Royaume-Uni] ; H. Bigalke [Allemagne] ; C. D. Marsden [Royaume-Uni] | Botulinum toxin antibody testing : Comparison between the mouse protection assay and the mouse lethality assay |
| 004F44 |
Dressler [Royaume-Uni] ; T. Scaravilli [Royaume-Uni] ; K. P. Bhatia [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Nicotine nasal spray is not reliable treatment for blepharospasm: Results of a pilot study |
| 005134 |
D. Dressler [Royaume-Uni] ; T. Scaravilli [Royaume-Uni] ; K. P. Bhatia [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Nicotine nasal spray is not reliable treatment for blepharospasm : Results of a pilot study |
| 005147 |
E. D. Playford [Royaume-Uni] ; R. E. Passingham [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; D. J. Brooks [Royaume-Uni] | Increased activation of frontal areas during arm movement in idiopathic torsion dystonia |
| 005155 |
M. G. Hanna [Royaume-Uni] ; M. B. Davis [Royaume-Uni] ; M. G. Sweeney [Royaume-Uni] ; M. Noursadeghi [Royaume-Uni] ; C. J. Ellis [Royaume-Uni] ; P. Elliot [Royaume-Uni] ; N. W. Wood [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Generalized chorea in two patients harboring the Friedreich's ataxia gene trinucleotide repeat expansion |
| 005394 |
Brown [Royaume-Uni] ; J. C. Rothwell [Royaume-Uni] ; J. M. Stevens [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Cerebellar axial postural tremor |
| 005452 |
K. J. Werhahn [Royaume-Uni] ; P. Brown [Royaume-Uni] ; P. D. Thompson [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | The clinical features and prognosis of chronic posthypoxic myoclonus |
| 005459 |
P. Brown [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; D. Barnes [Royaume-Uni] ; D. R. Wren [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Spinal rigidity following acute myelitis |
| 005477 |
D. Anastasopoulos [Grèce, Royaume-Uni] ; K. Bhatia [Royaume-Uni] ; A. Bisdorff [Royaume-Uni] ; A. M. Bronstein [Royaume-Uni] ; M. A. Gresty [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Perception of spatial orientation in spasmodic torticollis part I: The postural vertical |
| 005478 |
K. P. Bhatia [Royaume-Uni] ; V. L. Soland [Royaume-Uni] ; M. H. Bhatt [Inde] ; N. P. Quinn [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Paroxysmal exercise-induced dystonia : Eight new sporadic cases and a review of the literature |
| 005532 |
P. Brown [Royaume-Uni] ; J. C. Rothwell [Royaume-Uni] ; J. M. Stevens [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Cerebellar axial postural tremor |
| 005565 |
Quirk [Royaume-Uni] ; G. L. Sheean [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Treatment of nonoccupational limb and trunk dystonia with botulinum toxin |
| 005599 |
B. Zeng [Royaume-Uni] ; Jenner [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Partial reversal of increased preproenkephalin messenger ribonucleic acid (mRNA) and decreased preprotachykinin mRNA by foetal dopamine cells in unilateral 6‐Hydroxydopamine–Lesioned rat striatum parallels functional recovery |
| 005733 |
J. A. Quirk [Royaume-Uni] ; G. L. Sheean [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Treatment of nonoccupational limb and trunk dystonia with botulinum toxin |
| 005785 |
D. M. Kullmann [Royaume-Uni] ; R. S. Howard [Royaume-Uni] ; D. H. Miller [Royaume-Uni] ; N. P. Hirsch [Royaume-Uni] ; P. Brown [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Brainstem encephalopathy with stimulus-sensitive myoclonus leading to respiratory arrest, but with recovery : A description of two cases and review of the literature |
| 005849 |
Markus [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; G. Lennox [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; D. C. Costa [Royaume-Uni] | Patterns of regional cerebral blood flow in corticobasal degeneration studied using HMPAO SPECT; comparison with Parkinson's disease and normal controls |
| 005992 |
H. S. Markus [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; G. Lennox ; C. D. Marsden ; D. C. Costa | Patterns of regional cerebral blood flow in corticobasal degeneration studies using HMPAO SPECT ; comparison with Parkinson's disease and normal controls |
| 005B09 |
Brown [Royaume-Uni] ; J. C. Rothwell [Royaume-Uni] ; P. D. Thompson [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Propriospinal myoclonus: Evidence for spinal “pattern” generators in humans |
| 005B56 |
Gilles Fénelon [France] ; Annaék Fève [France] ; Avindra Nath [Canada] ; Douglas E. Hobson [Canada] ; A. H. V. Schapira [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; M. S. Sandy [États-Unis] ; J. W. Langston [États-Unis] ; D. A. Di Monte [États-Unis] ; James J. Gaul [États-Unis] | Letters to the editor |
| 005C02 |
S. Rose [Royaume-Uni] ; Jenner [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Chronic administration does not alter the accumulation of L‐dopa into muscle |
| 005C72 |
D. T. Dexter [Royaume-Uni] ; A. E. Holley ; W. D. Flitter ; T. F. Slater ; F. R. Wells ; S. E. Daniel ; Andrew Lees (neurologue) [Royaume-Uni] ; P. Jenner [Royaume-Uni] ; C. D. Marsden | Increated levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study |
| 005F31 |
Gibb [Royaume-Uni] ; L. Kilford [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Severe generalised dystonia associated with a mosaic pattern of striatal gliosis |
| 006001 |
Robert E. Burke [États-Unis] ; N. A. Fletcher [Royaume-Uni] ; A. E. Harding [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] ; S. Moghal [Canada] ; A. H. Rajput [Canada] ; Andrew J. Hughes [Royaume-Uni] ; Susan E. Daniel [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; G. W. Thickbroom ; F. L. Mastaglia ; J. Artieda [Espagne] ; J. A. Obeso [Espagne] ; R. J. Hardie [Royaume-Uni] ; R. A. Morgan-Hughes [Royaume-Uni] | Letters to the Editor |
| 006015 |
Steiger [Royaume-Uni] ; M. Pires [Royaume-Uni] ; F. Scaravilli [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Hemiballism and chorea in a patient with parkinsonism due to a multisystem degeneration |
| 006066 |
W. R. G. Gibb [Royaume-Uni] ; L. Kilford ; C. D. Marsden | Severe generalised dystonia associated with a mosaic pattern of striatal gliosis |
| 006422 |
Gibb [Royaume-Uni] ; M. Terruli [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; P. Jenner [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | The evolution and distribution of morphological changes in the nervous system of the common marmoset following the acute administration of 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine |
| 006424 |
Coleman [Royaume-Uni] ; K. W. Lange [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; A. E. Loper [États-Unis] ; J. V. Bondi [États-Unis] ; M. Hichens [États-Unis] ; S. M. Stahl [Royaume-Uni, États-Unis] ; C. D. Marsden [Royaume-Uni] | The antiparkinsonian actions and pharmacokinetics of transdermal (+)‐4‐Propyl‐9‐hydroxynaphthoxazine (+ PHNO): Preliminary results |
| 006493 |
W. R. G. Gibb ; M. Terruli ; Andrew Lees (neurologue) [Royaume-Uni] ; P. Jenner ; C. D. Marsden | The evolution and distribution of morphological changes in the nervous system of the common marmoset following the acute administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
| 006532 |
Gibb [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Pathological report of four patients presenting with cranial dystonias |
| 006537 |
Coleman [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Multiple sclerosis presenting as adult onset dystonia |
| 006576 |
W. R. G. Gibb ; Andrew Lees (neurologue) [Royaume-Uni] ; C. D. Marsden | Pathological report of four patients presenting with cranial dystonias |
| 006681 |
Leenders [Royaume-Uni] ; R. S. J. Frackowiak [Royaume-Uni] ; N. Quinn [Royaume-Uni] ; D. Brooks [Royaume-Uni] ; D. Sumner [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Ipsilateral blepharospasm and contralateral hemidystonia and parkinsonism in a patient with a unilateral rostral brainstem– thalamic lesion: Structural and functional abnormalities studied with CT, MRI, and PET scanning |
| 006697 |
Leenders [Royaume-Uni] ; R. S. J. Frackowiak [Royaume-Uni] ; N. Quinn [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Brain energy metabolism and dopaminergic function in Huntington's disease measured in vivo using positron emission tomography |
| 006701 |
J. Garvey [Royaume-Uni] ; M. Petersen ; C. M. Waters ; S. P. Rose [Royaume-Uni] ; S. Hunt ; R. Briggs ; P. Jenner [Royaume-Uni] ; C. D. Marsden [Royaume-Uni] | Administration of MPTP to the common marmoset does not alter cortical cholinergic function |
